Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

8.15
Delayed Data
As of May 31
 +0.04 / +0.49%
Today’s Change
5.88
Today|||52-Week Range
13.18
-22.08%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close8.11
Today’s open8.16
Day’s range8.02 - 8.27
Volume260,792
Average volume (3 months)343,232
Market cap$321.3M
Dividend yield--
Data as of 3:59pm ET, 05/31/2016

Growth & Valuation

Earnings growth (last year)-136.59%
Earnings growth (this year)-54.98%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-38.95%
P/E ratioNM
Price/Sales14.17
Price/Book4.68

Competitors

 Today’s
change
Today’s
% change
LJPCLa Jolla Pharmaceuti...+0.51+3.27%
RIGLRigel Pharmaceutical...+0.12+4.88%
NUTRNutraceutical Intern...-0.02-0.08%
LFVNLifeVantage Corp-1.04-7.69%
Data as of 3:59pm ET, 05/31/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$28.7M
Annual profit (last year)-$37.5M
Net profit margin-130.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Sharon A. Barbari
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs